Wet AMD 5 Symposium

Related

• 

  Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S

  Allen Chiang, MD, FASRS

  Annual Meeting Talks

  2019

• 

  Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II  AAVIATE Study

  Mark R. Barakat, MD

  Updates from the Field

  2021

• 

  What Do the HARBOR Data Reveal About the Relationship Between the Drying of Subretinal and Intraretinal Fluid and Associated Vision Outcomes?

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2019